Home Latest Articles
Latest Articles
  • Xilong QU, Hexin KONG, Zhong FENG, Guimin ZHANG
    Chinese Journal of Pharmaceuticals. 2026, 57(1): 110-117.

    A HPLC method was established for the simultaneous determination of seventeen related substances(2-18) in brexpiprazole(1) bulk drug. Separation was performed on a YMC Pack ODS-AQ column(4.6 mm×250 mm,5 μm) with 0.02 mol/L potassium dihydrogen phosphate solution(adjusting pH to 2.5 with phosphoric acid) as mobile phase A and acetonitrile as mobile phase B in the gradient elution mode. The flow rate was 1.0 mL/min, the detection wavelength was 215 nm, the column temperature was 30 ℃, and the injection volume was 10 μL. The correction factors of impurities 2-18 to the principal component were determined, and the main component self-comparison method with correction factors was established to determine seventeen known impurities. The results showed that the separation between the main component and various impurities was good, and it was linear for the main component and various impurities in the corresponding mass concentration ranges. The LOQs of 1-18 were 20.14 - 82.63 ng/mL, and the LODs were 6.71 -27.54 ng/mL. The average recoveries(n=9) of 2-18 were 91.66% - 101.83%, with the RSDs of 0.49% - 1.45%. The established method can be used for the determination of the related substances in 1 with high accuracy, good sensitivity and good specificity, repeatability.

  • Dan LI, Xu XU, Xiao ZHANG, Shanshan LU, Chunyan SUN
    Chinese Journal of Pharmaceuticals. 2026, 57(1): 118-121.

    A reversed-phase high-performance liquid chromatography(RP-HPLC) method was established for the simultaneous determination of p-fluoro isomer(2) and enantiomer(3) in safinamide mesylate(1). Separation was performed on a CHIRALPAK IG-3 chiral column (4.6 mm×250 mm,3 μm) with a mobile phase consisting of 0.05 mol/L ammonium bicarbonate solution and methanol at a volume ratio of 10∶90 under isocratic elution mode. The detection wavelength was set at 226 nm, the flow rate was 0.5 mL/min, and the column temperature was maintained at 15 ℃. The methodological studies showed that 2 and 3 had good linearity in the ranges of 0.16 - 1.62 and 0.16 - 1.57 μg/mL, respectively(r>0.99).Both the limit of detection(LOD) and limit of quantitation(LOQ) were determined to be 0.02 and 0.16 μg/mL, respectively.The average recoveries(n=9) of compounds 2 and 3 were 102.0% and 92.1%, with RSDs of 5.9% and 4.2%, respectively.This method is accurate, reliable and highly sensitive, which can be applicable for the quantitative determination of the two isomeric impurities in 1.

  • Ze XUAN, Ying YAO, Zhijie JIANG, Yihui PANG, Huan LIU, Langui XIE
    Chinese Journal of Pharmaceuticals. 2026, 57(1): 122-127.
  • Yan MA, Heqin WANG, Le YANG, Zirong LU, Qian GUO
    Chinese Journal of Pharmaceuticals. 2026, 57(1): 128-134.
  • Bin WU, Jianfen CHEN, Junli LI, Xuejie SONG
    Chinese Journal of Pharmaceuticals. 2026, 57(1): 135-139.
  • Mengyao LI, Huafei LUO, Huiyong ZHU, Hemin HUANG
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1493-1502.

    Solvent-free styrene-isoprene-styrene(SIS) block copolymer-based hot melt pressure sensitive adhesive(HMPSA) is commonly used as transdermal patch matrix due to its advantages of environmental protection,high adhesion strength and good drug compatibility. However, the aging problem in its long-term storage and use will lead to problems such as viscosity attenuation and abnormal drug release, which restricts its clinical application and industrialization promotion. This paper mainly introduces the material properties, aging types and mechanisms of solvent-free SIS-based HMPSA, systematically summarizes the aging characterization techniques and evaluation methods, and the current commonly used anti-aging strategies. Based on the existing research progress, this paper analyzes the advantages and limitations of different strategies, and puts forward the future research direction, aiming to provide a reference for the development of anti-aging properties of HMPSA for transdermal patches.

  • Zhuyun LIU, Weixiang HE, Shanshan YANG, Weilu GUO, Lizhong WANG
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1503-1513.

    Erdafitinib(1), a novel small-molecule targeted agent, is the first fibroblast growth factor receptor(FGFR) tyrosine kinase inhibitor approved for the treatment of advanced or metastatic bladder cancer. By selectively targeting genetic alterations in FGFR signaling pathways(such as mutations, fusions, or amplifications), it modulates cellular growth and division, thereby treating urothelial carcinoma of bladder and demonstrating broad clinical and commercial application prospects. This review systematically analyzes the synthetic strategies of 1, comprehensively reviews 9 reported synthetic routes of 1, and critically evaluates the advantages and limitations of each route. These above-mentioned insights aim to offer valuable references and guidance for the synthesis research and industrial-scale manufacture of 1 and its key intermediates.

  • Jie ZHUANG, Mengjie QI, Wenjing ZHANG, Jianzhao NIU, Qian LIU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1514-1523.

    Enteral tube administration is an important oral alternative treatment route for patients with dysphagia.However, its clinical application faces multiple challenges, such as insufficient standardization, lack of guidance in drug package inserts, and an immature in vitro evaluation system. The U.S. FDA has issued enteral tube administration technical guidelines for more than 30 types of drugs(e.g., esomeprazole capsules, rivaroxaban tablets), clearly specifying test parameters(including enteral tube diameter, types and volumes of dispersion medium, incubation time). Currently, the problem of missing or incomplete information related to enteral tube administration in the package inserts of generic drugs in China is prominent, which may lead to clinical operation errors and risks to drug stability. This article reviews the relevant technical guidelines for enteral tube administration, the current status and research progress of clinical applications at home and abroad, as well as the existing problems. It focuses on summarizing the key points to be noted when conducting in vitro comparative studies, aiming to provide technical suggestions for the design, implementation, and result evaluation of in vitro tests for oral drugs administered via enteral tubes.

  • Ping HUANG, Ruoqi WANG, Xuqing CHEN, Yuting WU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1524-1528.

    An optimized synthetic route for mirogabalin besylate(1), a drug for the treatment of diabetic neuropathic pain in adults, was developed using 3-ethylbicyclo[3.2.0]hept-3-ene-6-one(2) as the starting material. The process involved chemical resolution, Wittig-Horner reaction, Michael addition, nitro reduction, secondary resolution,deprotection, and salt formation. In this optimal route, key improvements included enhancing the chiral resolution method and optimizing the nitro reduction step, which mitigated safety risks from Raney nickel hydrogenation. The overall yield increased from 8% to 10.2% (based on 2), with HPLC purity of the targeted compound reaching 99.2%. Featuring simple operation and reliable product quality, this route is suitable for industrial production.

  • Bo WANG, Changgang TU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1529-1534.

    Sevoflurane(1) is a widely used inhalation anesthetic. To address the issues in existing synthetic techniques, this study developed the continuous gas phase synthesis of 1. Using Cr-Ce@C as the catalyst and hexafluoroisopropyl chloromethyl ether and hydrogen fluoride as raw materials, the gasified and mixed reactants flowed into the catalytic bed for a fluorine-chlorine exchange reaction. After 33 min of operation, the conversion rate of chloromethyl ether and the selectivity for 1 reached 92% and 97%, respectively. The isolated yield of target product 1 was 80% with a purity of 99%. This method demonstrated excellent selectivity, safe control, and showed significant potential for continuous large-scale production and automated process control.

News